Tarsons Products Completes Second Tranche of EUR 552,000 Investment in Subsidiary

Tarsons Products Ltd has completed the second tranche of its equity investment in its wholly-owned Singaporean subsidiary, Tarsons Life Science Pte. Ltd. This tranche amounts to EUR 552,000, with the company subscribing to 184 equity shares. This investment is part of a larger approved equity infusion of EUR 3,000,000. The funds will be utilized by the subsidiary for loan repayment, interest payments, and general corporate purposes. This follows the first tranche of EUR 300,000 completed earlier. The company will continue to provide updates on subsequent tranches.